Toby
0000-0002-6465-4578
1 paper found
Refreshing results…
A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Missing publications? Search for publications with a matching author name.